Method of treatment for eiph in racing stock

Details Method of treatment for eiph in racing stock Method of treatment for eiph in racing stock

1995-09-07

1996-08-27

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514254, 514393, 514423, 514929, A61K 31495, A61K 3130

Patent

active

055501273

ABSTRACT:
The prevention and treatment of exercise-induced pulmonary hemorrhaging in non-human mammals is accomplished by the timely administration of effective amounts of vasodilators, including angiotensin converting enzyme inhibitors such as lisinopril, enalapril and captopril, and angiotensin II blocking vasodilators such as losartan potassium.

REFERENCES:
patent: 4374829 (1983-02-01), Harris et al.
patent: 4686225 (1987-08-01), King
patent: 4722334 (1988-02-01), Blackmen et al.
patent: 4955372 (1990-09-01), Blackmen et al.
patent: 5128355 (1992-07-01), Carini et al.
patent: 5132118 (1992-07-01), Mills
patent: 5212165 (1993-05-01), Aberg et al.
Medline Abstract AW 89165550 (Nagai et al, Jul.-Aug. 1988).
Medline Abstract AW 94042697 (West et al, Sep. 1993).

Affiliated with

Also associated with

Rating

Method of treatment for eiph in racing stock does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment for eiph in racing stock, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment for eiph in racing stock will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1056303